Production of MMP-9 and inflammatory cytokines by Trypanosoma cruzi-infected macrophages

Experimental Parasitology

Volumn 147, Issue , 2014, Pages 72-80

  de Pinho, Rosa Teixeira ^a   da Silva, Wellington Seguins ^a,b   de Castro CÔrtes, Luzia Monteiro ^c   da Silva Vasconcelos Sousa, Periela ^a   de Araujo Soares, Renata Oliveira ^c   Alves, Carlos Roberto ^c  

^a Laboratório de Imunologia Clínica   (Brazil)

^b Centro de Pesquisas Arlindo de Assis   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Colombian strain; Cytokines; Human macrophages; IFN ; IL 1 ; IL 4; IL 6; Matrix metalloproteinase 9; Mouse macrophages; THP 1 macrophages; TNF ; Trypanosoma cruzi; Y strain

Indexed keywords

GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN SYNTHESIS; TRYPANOSOMA CRUZI; ZYMOGRAPHY; ANIMAL; BIOSYNTHESIS; CELL LINE; CHAGAS DISEASE; CYTOLOGY; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; MONOCYTE; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CHAGAS DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; MONOCYTES; TRYPANOSOMA CRUZI;

EID: 84910615847     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2014.09.003     Document Type: Article

References (53)

1. Andrade L.O., Andrews N.W. The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat. Rev. Microbiol 2005, 3:819-823.
2. Andrade S.G. Morphological and behavioural characterization of Trypanosoma cruzi strains. Rev. Soc. Bras. Med. Trop 1985, 18:39-46.
3. Andrade S.G., Grimaud J.A., Stocker-Guerret S. Sequential changes of the connective matrix components of the myocardium (fibronectin and laminin) and evolution of cardiac fibrosis in mice infected with Trypanosoma cruzi. Am. J. Trop. Med. Hyg 1989, 40:252-260.
4. Andrade Z.A. Extracellular matrix degradation in parasitic diseases. Braz. J. Med. Biol. Res 1994, 27:2273-2781.
5. Anonymous Recommendation from a satellite meeting. Memór. Instit. Oswal. Cruz 1999, 94:429-432.
6. Araújo Jorge T.C., Barbosa H.S., Moreira A.L., De Souza W., Meirelles M.N. The interaction of myotropic and macrophagotropic strains of Trypanosoma cruzi with myoblasts and fibers of skeletal muscle. Z. Parasitenkd 1986, 72:577-584.
7. Bautista-López N.L., Morillo C.A., López-Jaramillo P., Quiroz R., Luengas C., Silva S.Y., et al. Matrix metalloproteinases 2 and 9 as diagnostic markers in the progression to Chagas cardiomyopathy. Am. Heart J. 2013, 165:558-566.
8. Brown R.D., Jones G.M., Laird R.E., Hudson P., Long C.S. Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts. Biochem. Biophys. Res. Commun 2007, 362:200-205.
9. Cimmino G., Ragni M., Cirillo P., Petrillo G., Loffredo F., Chiariello M., et al. C-reactive protein induces expression of matrix metalloproteinase-9: a possible link between inflammation and plaque rupture. Int. J. Cardiol 2012, S0167-5273:1-6.
10. Corcoran M.L., Stetler-Stevenson W.G., Brown P.D., Wahl L.M. Interleukin inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem 1992, 267:515-519.
11. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
12. Dinarello C.A. Interleukin-1β. Crit. Care Med 2005, 33:S460-S462.
13. Elkington P.T., O'Kane C.M., Friedland J.S. The paradox of matrix metalloproteinases in infectious disease. Clin. Exp. Immunol 2005, 142:12-20.
14. Fan D., Takawale A., Lee J., Kassiri Z. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair 2012, 5(1):15.
15. Fares R.C., Gomes J.D., Garzoni L.R., Waghabi M.C., Saraiva R.M., Medeiros N.I., et al. Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas' disease. Infect. Immun 2013, IAI.00153-13.
16. Federici E.E., Abelman W.H., Neva F.A. Chronic and progressive myocarditis and myosite in C3H mice infected with Trypanosoma cruzi. Am. J. Trop. Med. Hyg 1964, 13:272-280.
17. Ferreira R.C., Ianni B.M., Abel L.C.J., Buck P., Mady C., Kalil J., et al. Increased plasma levels of tumor necrosis factor-a in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients. Memór. Insti. Oswal. Cruz 2003, 98:704-711.
18. Fichera F.E., Albareda M.C., Laucella S.A., Postan M. Intracellular growth of Trypanosoma cruzi in cardiac myocytes is inhibited by cytokine-induced nitric oxide release. Infect. Immun 2004, 72(1):359-363.
19. Gao C.Q., Sawicki G., Suarez-Pinzon W.L., Csont T., Wozniak M., Ferdinandy P., et al. Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovasc. Res 2003, 57:426-433.
20. Gebbia J.A., Coleman J.L., Benach J.L. Borrelia spirochetes upregulate release and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in human cells. Infect. Immun 2001, 69:456-462.
21. Geurts N., Opdenakker G., Van den Steen P.E. Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections. Pharmacol. Ther 2011, 133:257-279.
22. Gutierrez F.R., Lalu M.M., Mariano F.S., Milanezi C.M., Cena J., Gerlach R.F., et al. Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection. J. Infect. Dis 2008, 197:1468-1476.
23. Hoft D.F., Schnapp A.R., Eickhof C.S., Roodman S.T. Involvement of CD4+ Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infect. Immun 2000, 68:197-204.
24. Hosomi N., Ban C., Naya T., Takahashi T., Guo P., Song Y., et al. Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia. J. Cereb. Blood Flow Metabol 2005, 25:959-967.
25. Hovsepian E., Mirkin G.A., Penas F., Manzano A., Bartrons R., Goren N.B. Modulation of inflammatory response and parasitism by 15-Deoxy-δ(12,14) prostaglandin J(2) in Trypanosoma cruzi-infected cardiomyocytes. Intent. J. Parasitol 2011, 41(5):553-562.
26. Lee H.S., Shin H.H., Kwon B.S., Choi H.S. Soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) increased MMP-9 activity in murine macrophage. J. Cell. Biochem 2003, 88:1048-1056.
27. Liang K.C., Lee C.W., Lin W.N., Lin C.C., Wu C.B., Luo S.F., et al. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappa B signaling pathways in human tracheal smooth muscle cells. J. Cell. Physiol 2007, 211:759-770.
28. Lowry H., Rosebrough N.J., Farr L., Randall R.J. Protein measurement with the Folin reagent. J. Biol. Chem 1951, 193(1):265-275.
29. Magalhaes-Santos I.F., Andrade S.G. Participation of cytokines in the necrotic-inflammatory lesions in the heart and skeletal muscles of Calomys callosus infected with Trypanosoma cruzi. Memór. Instit. Oswal. Cruz 2005, 100:555-561.
30. Malvezi A.D., da Silva R.V., Panis C., Yamauchi L.M., Lovo-Martins M.I., Zanluqui N.G., et al. Aspirin modulates innate inflammatory response and inhibits the entry of Trypanosoma cruzi in mouse peritoneal macrophages. Mediators Inflamm 2014, 580919.
31. Mertz P.M., DeWitt D.L., Stetler-Stevenson W.G., Wahl L.M. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J. Biol. Chem 1994, 269:21322-21329.
32. Moncayo A., Ortiz Yanine M.I. An update on Chagas' disease (human American trypanosomiasis). Ann. Trop. Med. Parasitol 2006, 100:663-677.
33. Muñoz-Fernández M.A., Fernández M.A., Fresno M. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur. J. Immunol 1992, 22:301-307.
34. Nguyen J., Knapnougel P., Lesavre P., Bauvois B. Inhibition of matrix metalloproteinase-9 by interferons and TGF-beta1 through distinct signalings accounts for reduced monocyte invasiveness. FEBS Lett 2005, 579:5487-5493.
35. Okada M., Suzuki A., Yamawaki H., Hara Y. Levosimendan inhibits interleukin-1β-induced cell migration and MMP-9 secretion in rat cardiac fibroblasts. Eur. J. Pharmacol 2013, 718(1-3):332-339.
36. Pinho R.T., Vannier-Santos M.A., Alves C.R., Marino A.P., Castello Branco L.R., Lannes-Vieira J. Effect of Trypanosoma cruzi released antigens binding to non-infected cells on anti-parasite antibody recognition and expression of extracellular matrix components. Acta Trop 2002, 83:103-115.
37. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther 2009, 123:255-278.
38. Quiding-Järbrink M., Smith D.A., Bancroft G.J. Production of matrix metalloproteinases in response to mycobacterial infection. Infect. Immun 2001, 69:5661-5670.
39. Ramsey K.H., Sigar I.M., Schripsema J.H., Shaba N., Cohoon K.P. Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum. Infect. Immun 2005, 73:6962-6973.
40. Reed S.G. In vivo administration of recombinant IFN-γ induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi. Infect. J. Immunol 1988, 140:4342-4347.
41. Risso M.G., Garbarino G., Mocetti E., Campetella O., Gonzalez Cappa S.M., Buscaglia C.A., et al. Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages. J. Infect. Dis 2004, 189:2250-2259.
42. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998, 29:1020-1030.
43. Roose J.P., Van Noorden C.J. Synthetic protease inhibitors: promising compounds to arrest pathobiologic processes. J. Lab. Clin. Med 1995, 125:433-444.
44. Scheller J., Ohnesorge N., Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand. J. Immunol 2006, 63:321-329.
45. Shapiro S.D., Campbell E.J., Kobayashi D.K., Welgus H.G. Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J. Clin. Invest 1990, 86:1204-1210.
46. Shishodia S., Majumdar S., Banerjee S., Aggarwal B.B. Ursolic acid inhibits nuclear factor-kappa B activation induced by carcinogenic agents through suppression of Ikappa B alpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res 2003, 63:4375-4383.
47. Silva L.H.P., Nussenzweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folha Clìn. Biol 1953, 20:191-207.
48. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol 2001, 17:463-516.
49. Unnikrishnan M., Burleigh B.A. Inhibition of host connective tissue growth factor expression: a novel Trypanosoma cruzi-mediated response. FASEB Journal 2004, 18:1625-1635.
50. WHO - World Health Organization Chagas' disease (American trypanosomiasis) accessed 13.07.30. http://www.who.int/mediacentre/factsheets/fs340/en/index.html.
51. Xie Z., Singh M., Singh K. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1β. J. Chem. Biol 2004, 279:39513-39519.
52. Zhang Y., McCluskey K., Fujii K., Wahl L.M. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J. Immunol 1998, 161:3071-3076.
53. Zhou M., Gu L., Zhu N., Woods W., Findley H. Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53. Oncogene 2003, 22:8137-8144.